Spiking Insulin Costs Put Patients in Brutal Bind Spiking Insulin Costs Put Patients in Brutal Bind
Insulin prices have skyrocketed in recent years, on average tripling between 2002 and 2013. One popular brand, NovoLog, increased in list price by 353% from 2001 to 2016.WebMD Health News (Source: Medscape Medical News Headlines)
Source: Medscape Medical News Headlines - August 2, 2018 Category: Consumer Health News Tags: Diabetes & Endocrinology News Source Type: news

Valeritas touts use of V-Go device compared to insulin injections
Valeritas (NSDQ:VLRX) touted data today from an analysis showing that insulin-dependent people with Type 2 diabetes benefited from using the company’s wearable V-Go insulin delivery device. The study featured people who previously treated their diabetes using multiple daily injections of insulin. After switching to the V-Go device under the care of advanced practitioners, participants were monitored and evaluated at the three- and seventh-month mark. Get the full story at our sister site, Drug Delivery Business News. The post Valeritas touts use of V-Go device compared to insulin injections appeared first on Mas...
Source: Mass Device - August 2, 2018 Category: Medical Devices Authors: Sarah Faulkner Tags: Diabetes Drug-Device Combinations Pharmaceuticals Wall Street Beat Valeritas Source Type: news

Insulin resistance under-diagnosed in non-diabetics with Parkinson's disease
(IOS Press) Almost two-thirds of non-diabetic patients with Parkinson's disease (PD) may be insulin resistant, despite having normal blood sugar, report scientists in the Journal of Parkinson's Disease. Their findings suggest that insulin resistance in PD is a common and largely undetected problem, especially in patients who are overweight. (Source: EurekAlert! - Medicine and Health)
Source: EurekAlert! - Medicine and Health - August 2, 2018 Category: International Medicine & Public Health Source Type: news

DexCom Surpassed Analyst Expectations in the Second Quarter
Diabetes patients are clamoring to get their hands on DexCom's newest gadget, the G6 continuous glucose monitoring (CGM) system. FDA approved the device in March and the company decided to get the product into customer's hands as soon as possible, even though it had originally planned to launch the device in the second half of the year, CEO Kevin Sayer explained Wednesday during DexCom's second-quarter earnings call. The company ended up launching the new device with about three weeks left in the second quarter. The device is the CGM to score approval as an interoperable CGM, meaning that it can work with other automated i...
Source: MDDI - August 1, 2018 Category: Medical Devices Authors: Amanda Pedersen Tags: Business Source Type: news

What Is Intermittent Fasting And Is It Actually Good For You?
Sustainable weight loss. Protection from diabetes, heart disease and cancer. Improved brain health. Enhanced physical fitness and strength. It seems like every week, researchers turn up some new and profound benefit associated with intermittent fasting: eating schedules that incorporate regular periods of low or no food consumption. By eating normally for several days a week and eating much less on the others, a person may be able to shift her body’s cellular and metabolic processes in ways that promote optimal health. And experts who study intermittent fasting say that while many blanks still need to be filled in, s...
Source: TIME: Health - August 1, 2018 Category: Consumer Health News Authors: Markham Heid Tags: Uncategorized Diet/Nutrition healthytime Source Type: news

Valeritas launches V-Go insulin delivery device in New Zealand
Valeritas (NSDQ:VLRX) said today that its V-Go wearable insulin delivery device is now available in New Zealand thanks to an exclusive distribution deal with NZMS Diabetes. According to the terms of the agreement, Valeritas will be responsible for product development, regulatory approval, manufacturing and quality management while NZMS Diabetes will take over the sales, marketing, customer support and distribution responsibilities in New Zealand. Get the full story at our sister site, Drug Delivery Business News. The post Valeritas launches V-Go insulin delivery device in New Zealand appeared first on MassDevice. (Source: Mass Device)
Source: Mass Device - August 1, 2018 Category: Medical Devices Authors: Sarah Faulkner Tags: Diabetes Drug-Device Combinations Pharmaceuticals Wall Street Beat Valeritas Source Type: news

Food science: Indian herbs found to have profound protective effects against diabetes and Alzheimer's
(Natural News) Alzheimer’s disease and type 2 diabetes have been linked to each other. When a person has diabetes, Alzheimer’s is more likely to occur too – most likely because of the insulin resistance, oxidative stress, and inflammation diabetes causes. Because of this, researchers at Yogi Vemana University in India aimed to develop natural powerful... (Source: NaturalNews.com)
Source: NaturalNews.com - August 1, 2018 Category: Consumer Health News Source Type: news

French drug maker Sanofi stockpiling for Brexit
Sanofi is building a 14 week stockpile of drugs, including insulin, in case of Brexit disruptions. (Source: BBC News | Health | UK Edition)
Source: BBC News | Health | UK Edition - August 1, 2018 Category: Consumer Health News Source Type: news

Phys Ed: Take a Vacation From Exercise? Your Body May Not Thank You
Two new studies look at what happens when we do not exercise or move around much for a period of time. (Source: NYT Health)
Source: NYT Health - August 1, 2018 Category: Consumer Health News Authors: GRETCHEN REYNOLDS Tags: Diabetes Exercise Insulin Muscles Elderly Source Type: news

New FDA Watch List Has Warnings
New FDA Watch List Has Insulin Pens, Muscle Relaxants, and More (Source: eMedicineHealth.com)
Source: eMedicineHealth.com - August 1, 2018 Category: General Medicine Source Type: news

Insulin Pens, Muscle Relaxants Prominent on New FDA Watch List Insulin Pens, Muscle Relaxants Prominent on New FDA Watch List
The updates alert physicians to new safety information or possible signs of serious risk with a drug or drug class. Making the list, however, does not mean that the FDA has determined that a drug has the risk.Medscape Medical News (Source: Medscape Medical News Headlines)
Source: Medscape Medical News Headlines - July 31, 2018 Category: Consumer Health News Tags: Family Medicine/Primary Care News Source Type: news

New FDA Watch List Has Insulin Pens, Muscle Relaxants, and More New FDA Watch List Has Insulin Pens, Muscle Relaxants, and More
The updates alert physicians to new safety information or possible signs of serious risk with a drug or drug class. Making the list, however, does not mean that the FDA has determined that a drug has the risk.Medscape Medical News (Source: Medscape Today Headlines)
Source: Medscape Today Headlines - July 31, 2018 Category: Consumer Health News Tags: Family Medicine/Primary Care News Source Type: news

Docs' Beliefs Guide Prescribing of Glucose Monitoring in T2D Docs' Beliefs Guide Prescribing of Glucose Monitoring in T2D
Many primary care physicians still prescribe routine self-blood glucose monitoring to patients with type 2 diabetes not on insulin, despite evidence that it increases cost without improving outcomes.Medscape Medical News (Source: Medscape Medical News Headlines)
Source: Medscape Medical News Headlines - July 31, 2018 Category: Consumer Health News Tags: Diabetes & Endocrinology News Source Type: news

Tandem posts mixed Q2 results
Shares in Tandem Diabetes Care (NSDQ:TNDM) fell this week after the insulin pump maker topped sales expectations but missed earnings estimates on Wall Street with its second-quarter financial results. The San Diego, Calif.-based company posted a net loss of -$59.4 million on sales of $34.1 million for the 3 months ended June 30, for sales growth of 60% compared with the same period last year. Get the full story at our sister site, Drug Delivery Business News. The post Tandem posts mixed Q2 results appeared first on MassDevice. (Source: Mass Device)
Source: Mass Device - July 31, 2018 Category: Medical Devices Authors: Sarah Faulkner Tags: Diabetes MassDevice Earnings Roundup Pharmaceuticals Wall Street Beat tandemdiabetes Source Type: news

SFC Fluidics lands JDRF support for interoperable insulin patch pump
SFC Fluidics said today that it inked a deal with JDRF to support the development of an insulin patch pump with open-protocol communication features. SFC Fluidics plans to use the two-year funding deal from JDRF to speed up the development of a patch pump that securely connects with other devices, like a continuous glucose monitor and third-party algorithms, to automate insulin delivery. Get the full story at our sister site, Drug Delivery Business News. The post SFC Fluidics lands JDRF support for interoperable insulin patch pump appeared first on MassDevice. (Source: Mass Device)
Source: Mass Device - July 30, 2018 Category: Medical Devices Authors: Sarah Faulkner Tags: Diabetes Drug-Device Combinations Funding Roundup Pharmaceuticals Juvenile Diabetes Research Foundation (JDRF) sfcfluidics Source Type: news

Effects of Diazoxide on Glucose and Lipid Metabolism Effects of Diazoxide on Glucose and Lipid Metabolism
Could treatment with diazoxide help reduce insulin levels without increasing glucose levels?Journal of Clinical Endocrinology & Metabolism (Source: Medscape Today Headlines)
Source: Medscape Today Headlines - July 30, 2018 Category: Consumer Health News Tags: Diabetes & Endocrinology Journal Article Source Type: news

Are you experiencing these easily-missed symptoms of diabetes? Watch out for these warning signs
(Natural News) If a patient has Type 1 diabetes, their pancreas can’t produce enough insulin. If they have pre-diabetes or Type 2 diabetes, their body can’t use insulin efficiently. Individuals with diabetes also have high blood sugar levels since their body can’t sufficiently move the energy they receive from food out of their bloodstream and into their cells.... (Source: NaturalNews.com)
Source: NaturalNews.com - July 30, 2018 Category: Consumer Health News Source Type: news

Diabetic Koala at the San Diego Zoo Gets Help from the Latest in CGM
Quincy, a diabetic koala at the San Diego Zoo, is rocking a wearable new technology these days that may make his life—and maybe even other animals lives—much easier. Turns out that humans aren’t the only ones that suffer from diabetes. Many mammals also get it. To manage diabetes, patients must monitor their blood glucose closely. Sometimes this means finger sticks multiple times a day to get correct readings and to make sure that insulin doses are accurate. In humans, this is unpleasant. But for animals, it’s worse because of course they donâ...
Source: MDDI - July 28, 2018 Category: Medical Devices Authors: Susan Shepard Tags: Business Source Type: news

Novo Nordisk exec: In the digital age, it ’ s not enough to have a better molecule
Much of Dr. Todd Hobbs’ life has centered around diabetes – he was diagnosed with Type I diabetes roughly 30 years ago and now he is the father of a child with diabetes. At his Kentucky-based primary care practice, he took on diabetic patients and helped manage their care. And when he made the jump from the clinic to the pharmaceutical industry 15 years ago, he accepted a job at Novo Nordisk (NYSE:NVO). He now serves as VP & CMO of the insulin-maker’s North America unit. Between his work as a doctor and as an executive, he has watched healthcare trends come and go. The one that he’s ke...
Source: Mass Device - July 27, 2018 Category: Medical Devices Authors: Sarah Faulkner Tags: Diabetes mHealth (Mobile Health) Pharmaceuticals Wall Street Beat Novo Nordisk Source Type: news

PI3K Inhibitors and Keto Diet Better Than Drug Alone
Many mesothelioma experts believe the route to better disease management — and possibly a cure — lies with drugs that target genes and cell pathways that promote cancer growth. New research published July 4 in the journal Nature supports a novel approach for making PI3K inhibitors, medications that inhibit cancer growth, more effective. Trials on these drugs have been mixed, and now cancer experts may know why. PI3K inhibitors seem to work poorly in the presence of high glucose (sugar) and insulin levels. The new study in cells and mice shows reducing glucose and insulin with a ketogenic diet, popularly known ...
Source: Asbestos and Mesothelioma News - July 27, 2018 Category: Environmental Health Authors: Matt Mauney Source Type: news

Insulin-like peptide key in defining ant social castes
A new study inScience reports that the division of labour in ants may be defined by a single gene coding for ILP2, the ant version of insulin.Science Daily (Source: Society for Endocrinology)
Source: Society for Endocrinology - July 27, 2018 Category: Endocrinology Source Type: news

Diabetes type 1: Drink this much apple juice to help maintain blood sugar levels
DIABETES type 1 could occur either at birth or during adult life. The lifelong condition is caused by problems in the pancreas, meaning insulin is no longer produced. As a result, diabetes type 1 sufferers need to take steps to monitor blood sugar levels. (Source: Daily Express - Health)
Source: Daily Express - Health - July 27, 2018 Category: Consumer Health News Source Type: news

Diabetes and Dollars: Cost-of-Care Quiz
True or False: In 2015, Americans spent more on insulin glargine than any other drug. The answer and 9 more questions in our quiz. (Source: ConsultantLive)
Source: ConsultantLive - July 27, 2018 Category: Internal Medicine Authors: Grace Halsey Tags: Diabetes Source Type: news

Trilobites: Worker Ants: You Could Have Been Queens
Whether an ant becomes a worker or colony royalty may depend on insulin metabolism. (Source: NYT Health)
Source: NYT Health - July 26, 2018 Category: Consumer Health News Authors: KAREN WEINTRAUB Tags: Insects Genetics and Heredity Insulin Ants Biology and Biochemistry Rockefeller University Daniel Kronauer Source Type: news

Intermittent Fasting or Low-Cal Diet? Similar HbA1c Drop Intermittent Fasting or Low-Cal Diet? Similar HbA1c Drop
However, for'patients using sulfonylureas and/or insulin, intermittent energy restriction requires medication changes and regular monitoring, especially in the initial stages,'researchers caution.Medscape Medical News (Source: Medscape Medical News Headlines)
Source: Medscape Medical News Headlines - July 26, 2018 Category: Consumer Health News Tags: Diabetes & Endocrinology News Source Type: news

Dizziness from standing up may mean higher risk of dementia
People with orthostatic hypotension in middle age had 54% higher risk of developing dementia Related items fromOnMedica Hypertension raises risk of mitral regurgitation Dementia and stroke funding remains too low, say experts Stroke can often be avoided, claims study Adding insulin to metformin linked to higher mortality Stroke rates rocket in younger men and women (Source: OnMedica Latest News)
Source: OnMedica Latest News - July 26, 2018 Category: UK Health Source Type: news

Social regulation of insulin signaling and the evolution of eusociality in ants
Queens and workers of eusocial Hymenoptera are considered homologous to the reproductive and brood care phases of an ancestral subsocial life cycle. However, the molecular mechanisms underlying the evolution of reproductive division of labor remain obscure. Using a brain transcriptomics screen, we identified a single gene, insulin-like peptide 2 (ilp2), which is always up-regulated in ant reproductives, likely because they are better nourished than their nonreproductive nestmates. In clonal raider ants (Ooceraea biroi), larval signals inhibit adult reproduction by suppressing ilp2, thus producing a colony reproductive cycl...
Source: ScienceNOW - July 26, 2018 Category: Science Authors: Chandra, V., Fetter-Pruneda, I., Oxley, P. R., Ritger, A. L., McKenzie, S. K., Libbrecht, R., Kronauer, D. J. C. Tags: Anatomy, Morphology, Biomechanics, Evolution reports Source Type: news

Spiking Insulin Costs Put Patients in Brutal Bind
Insulin prices have skyrocketed in recent years, on average tripling between 2002 and 2013. One popular brand, NovoLog, increased in list price by 353% from 2001 to 2016. (Source: WebMD Health)
Source: WebMD Health - July 25, 2018 Category: Consumer Health News Source Type: news

Type-1 diabetes may induce metabolic disorders in offspring
According to a new study inDiabetologia, children born to mothers with type-1 diabetes are at a higher risk of being overweight or presenting insulin resistance.News Medical (Source: Society for Endocrinology)
Source: Society for Endocrinology - July 24, 2018 Category: Endocrinology Source Type: news

When We Eat, or Don ’ t Eat, May Be Critical for Health
A growing body of research suggests that our bodies function optimally when we align our eating patterns with our circadian rhythms. (Source: NYT Health)
Source: NYT Health - July 24, 2018 Category: Consumer Health News Authors: ANAHAD O ’ CONNOR Tags: Food Diabetes Biorhythms Weight Obesity Diet and Nutrition Sleep Snack Foods Insulin Source Type: news

Roche wins CE Mark for Accu-Chek Solo insulin micropump
Roche (OTC:RHHBY) said today that it won CE Mark clearance for its Accu-Chek Solo insulin micropump system. The company plans to launch a pilot commercialization phase for its device in the coming weeks in Austria, Poland, Switzerland and the U.K. Get the full story at our sister site, Drug Delivery Business News. The post Roche wins CE Mark for Accu-Chek Solo insulin micropump appeared first on MassDevice. (Source: Mass Device)
Source: Mass Device - July 23, 2018 Category: Medical Devices Authors: Sarah Faulkner Tags: Diabetes Drug-Device Combinations Pharmaceuticals Regulatory/Compliance Wall Street Beat Roche Source Type: news

Diabetes type 2: This protein-rich food could help lower blood sugar levels
DIABETES type 2 happens when there are problems with the hormone insulin, meaning the body can ’t regulate blood sugar levels normally. Sufferers may need to change their diet to better enable the body to control blood sugar. Eating this could help control blood sugar levels. (Source: Daily Express - Health)
Source: Daily Express - Health - July 23, 2018 Category: Consumer Health News Source Type: news

Depleting microbiome with antibiotics can affect glucose metabolism
(Salk Institute) A new study from the Salk Institute has found that mice that have their microbiomes depleted with antibiotics have decreased levels of glucose in their blood and better insulin sensitivity. The research has implications for understanding the role of the microbiome in diabetes. It also could lead to better insight into the side effects seen in people who are being treated with high levels of antibiotics. The study appeared in the journalNature Communications on July 20, 2018. (Source: EurekAlert! - Medicine and Health)
Source: EurekAlert! - Medicine and Health - July 23, 2018 Category: International Medicine & Public Health Source Type: news

Diabetes symptoms: Warning signs you could be developing blood sugar problems
DIABETES type 2 symptoms are triggered when there are problems with blood sugar levels. This is because of problems with the hormone insulin, which affects cells ’ ability to take in sugar. It is possible to develop ‘borderline’ diabetes, or pre diabetes, before the condition. Watch out for these symptoms. (Source: Daily Express - Health)
Source: Daily Express - Health - July 22, 2018 Category: Consumer Health News Source Type: news

Diabetes type 2 diet: Eat this high-fibre food to help lower blood sugar levels
DIABETES type 2 is a condition where the body cannot control blood sugar levels due to problems with the hormone insulin. For sufferers, it is important to avoid high blood sugar levels which, if lasting for long periods, could cause vision problems or a coma. Adding these seeds to someone ’s diet could help reduce blood sugar levels. (Source: Daily Express - Health)
Source: Daily Express - Health - July 21, 2018 Category: Consumer Health News Source Type: news

Companion Medical wins CE Mark for InPen insulin pen
Companion Medical said yesterday that it won CE Mark approval in the European Union for its InPen smart insulin pen and associated diabetes management smartphone application. The company’s InPen system consists of a smart insulin injection pen that connects with an integrated diabetes management app. Read the whole story on our sister site, Drug Delivery Business News The post Companion Medical wins CE Mark for InPen insulin pen appeared first on MassDevice. (Source: Mass Device)
Source: Mass Device - July 20, 2018 Category: Medical Devices Authors: Fink Densford Tags: Diabetes Drug-Device Combinations Regulatory/Compliance Companion Medical Source Type: news

Apidra (Insulin Glulisine [rDNA origin] Inj) - updated on RxList
(Source: RxList - New and Updated Drug Monographs)
Source: RxList - New and Updated Drug Monographs - July 20, 2018 Category: Drugs & Pharmacology Source Type: news

Is Abbott Losing Share in Key Medtech Markets?
By and large, Abbott Laboratories had a phenomenal second quarter this year – and investors took notice. The company's stock hit its highest point since 1995 on Wednesday after beating Wall Street's quarterly expectations and raising its own outlook for 2018. Abbott, MD+DI's 2017 Medtech Company of the Year, clearly has a lot to celebrate as it continues to show the world what its made of. But at least one medtech analyst noticed that the company appears to have lost market share in cardiac rhythm management (CRM) and neuromodulation. Abbott reported CRM sales of $543 million in the second quarter, representing ...
Source: MDDI - July 18, 2018 Category: Medical Devices Authors: Amanda Pedersen Tags: Business Cardiovascular Source Type: news

Medtronic Pumps Confidence in MiniMed Through Performance Guarantee
Medtronic has been leading the industry in the charge toward value-based care, and its efforts have been paying off in spades, as MD+DI has recently observed. Now, the company has found yet another way to stay ahead of the curve. The company recently launched a new performance guarantee program around its MiniMed 670G insulin pump. The new program is an outcomes-based offering for payers and employers designed to mitigate costs for diabetes-related complications. With this guarantee, Medtronic said it will provide flat-fee reimbursements of up to $25,000 per pump over four years for qualifying diabetes-related inpatient ho...
Source: MDDI - July 18, 2018 Category: Medical Devices Authors: Amanda Pedersen Tags: Business Source Type: news

Diabetes type 1 symptoms: Seven signs an adult has blood sugar problems
DIABETES type 1 symptoms may appear in adult life, not just at birth. The condition is caused by problems with the pancreas, which stops it producing the hormone to control blood sugar levels, insulin, which results in unexplained weight loss if not treated. This woman developed diabetes type 1 symptoms during adulthood. (Source: Daily Express - Health)
Source: Daily Express - Health - July 18, 2018 Category: Consumer Health News Source Type: news

Basal Insulin Analogues Similar for Glucose Lowering
WEDNESDAY, July 18, 2018 -- Basal insulin analogues for type 2 diabetes mellitus (T2DM) do not substantially differ in their glucose-lowering effect, according to a review published online July 10 in the Annals of Internal... (Source: Drugs.com - Pharma News)
Source: Drugs.com - Pharma News - July 18, 2018 Category: Pharmaceuticals Source Type: news

Diabetes symptoms: Seven warning signs you have the condition
DIABETES type 1 symptoms may appear in adult life, not just at birth. The condition is caused by problems with the pancreas, which stops it producing the hormone to control blood sugar levels, insulin, which results in unexplained weight loss if not treated. This woman developed diabetes type 1 symptoms during adulthood. (Source: Daily Express - Health)
Source: Daily Express - Health - July 18, 2018 Category: Consumer Health News Source Type: news

Diabetes symptoms: This change in your waistline could be a warning sign
DIABETES type 1 symptoms may appear in adult life, not just at birth. The condition is caused by problems with the pancreas, which stops it producing the hormone to control blood sugar levels, insulin, which results in unexplained weight loss if not treated. This woman developed diabetes type 1 symptoms during adulthood. (Source: Daily Express - Health)
Source: Daily Express - Health - July 18, 2018 Category: Consumer Health News Source Type: news

Diabetes type 1 symptoms: This woman lost 10 kg in a week before being diagnosed
DIABETES type 1 symptoms may appear in adult life, not just at birth. The condition is caused by problems with the pancreas, which stops it producing the hormone to control blood sugar levels, insulin, which results in unexplained weight loss if not treated. This woman developed diabetes type 1 symptoms during adulthood. (Source: Daily Express - Health)
Source: Daily Express - Health - July 18, 2018 Category: Consumer Health News Source Type: news

Diabetes type 1 symptoms: Unexplained weight loss? This woman lost 10 kg before diagnosis
DIABETES type 1 symptoms may appear in adult life, not just at birth. The condition is caused by problems with the pancreas, which stops it producing the hormone to control blood sugar levels, insulin, which results in unexplained weight loss if not treated. This woman developed diabetes type 1 symptoms during adulthood. (Source: Daily Express - Health)
Source: Daily Express - Health - July 18, 2018 Category: Consumer Health News Source Type: news

Little Difference Between Basal Insulin Analogs for Type 2 Diabetes Little Difference Between Basal Insulin Analogs for Type 2 Diabetes
Evidence comparing old versus new insulin analogs is poor quality. There are'many options'and'high price tags'but'little ability to discern the potential benefits of one...versus another,'said one commentator.Medscape Medical News (Source: Medscape Medical News Headlines)
Source: Medscape Medical News Headlines - July 17, 2018 Category: Consumer Health News Tags: Diabetes & Endocrinology News Source Type: news

Deadly Respiratory Distress Mimic
Medic 534, staffed by a paramedic and EMT, is dispatched to a nursing home for a 78-year-old female in respiratory distress. On arrival, the crew finds the patient in a chair accompanied by two nurses and the administrator on call. The patient is in obvious distress showing fatigue and an increased work of breathing. She is alert to voice, but diaphoretic, lethargic, and unable to speak due to rapid, shallow breathing. A nurse is administering a nebulizer containing 3 mL of albuterol sulfate/ipratropium. A second nurse states that the patient has been in increasing distress for the last 45 minutes. The nurse also says that...
Source: JEMS Patient Care - July 17, 2018 Category: Emergency Medicine Authors: Brenton Faber, PhD, NRP Tags: Airway & Respiratory Patient Care Source Type: news

Deadly Respiratory Distress Mimic
Conclusion It’s important for prehospital providers to be able to differentiate metabolic disturbances in the setting of respiratory distress and not be fooled into thinking tachypnea always has a respiratory cause. The physical exam and adjuncts such as end-tidal capnography can assist in the prehospital diagnosis. A COPD exacerbation generally presents as diminished lung sounds, wheezing on exhalation, and a prolonged expiratory phase. Here, a patient will attempt to compensate for the inflammation and mucus accumulation associated with the destruction and narrowing of peripheral airways and a subsequent lack of av...
Source: JEMS Special Topics - July 17, 2018 Category: Emergency Medicine Authors: Brenton Faber, PhD, NRP Tags: Airway & Respiratory Exclusive Articles Patient Care Source Type: news

CeQur acquires wearable insulin delivery device
CeQur said today that it acquired a wearable, on-demand insulin delivery system from Johnson & Johnson‘s (NYSE:JNJ) Calibra Medical for an undisclosed amount. The Calibra device is designed to dose rapid-acting, mealtime insulin for people with Type II diabetes. In a 278-person study, use of the Calibra device resulted in higher ease-of-use and patient satisfaction scores, as well as less glycemic variability compared to insulin injection pens. Get the full story at our sister site, Drug Delivery Business News. The post CeQur acquires wearable insulin delivery device appeared first on MassDevice. (Source: Mass Device)
Source: Mass Device - July 17, 2018 Category: Medical Devices Authors: Sarah Faulkner Tags: Diabetes Drug-Device Combinations Mergers & Acquisitions Pharmaceuticals Calibra Medical Inc. CeQur Ltd. johnsonandjohnson Source Type: news

Marlborough's CeQur revives expansion plans after buying J & J insulin device
CeQur CEO Bob Farra said the company plans to boost headcount with the addition of OneTouch, a wearable insulin delivery system. (Source: bizjournals.com Health Care:Pharmaceuticals headlines)
Source: bizjournals.com Health Care:Pharmaceuticals headlines - July 17, 2018 Category: Pharmaceuticals Authors: Allison DeAngelis Source Type: news